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LM-MLA cutoff value should be prospectively vali-
dated. In the LITRO (4), a prospective multicenter
study including 354 patients, the 6-mm2 cutoff value
was clinically validated. At 2 years, the outcome
of deferred patients was equivalent to that of the
revascularized group. Importantly, the outcome of
the few patients with 5- to 6-mm2 LM-MLA who
did not undergo revascularization was signiﬁcantly
worse. Last but not least, the LM-MLA cutoff value
is just aimed to exclude the presence of current
ischemia. However, 36% of patients in the study by
Park et al. (1) with “isolated” LM disease presented
as an acute coronary syndrome, and on intravascu-
lar ultrasound, plaque ruptures (30.6%) and intra-
coronary thrombi (33.3%) were readily observed.
It is difﬁcult to believe that the fate of these unsta-
ble plaques may be only dictated by the hemody-
namic signiﬁcance encountered at the time of the
examination.
We strongly believe that the provocative proposal
of 4.5 mm2 as an LM-MLA optimal cutoff value should
be taken very cautiously until further clinical data
support its prognostic validity.
*Jose M. de la Torre Hernández, MD, PhD
Felipe Hernández, MD
Fernando Alfonso, MD, PhD
*Hospital Universitario Marqués de Valdecilla
Unidad de Hemodinámica y Cardiología Intervencionista
Avda. Valdecilla s/n
Santander
Cantabria 39008
Spain
E-mail: he1thj@humv.es
http://dx.doi.org/10.1016/j.jcin.2014.09.011
Please note: Dr. de la Torre Hernández has received research grants from Abbott
Vascular, Boston Scientiﬁc, Biosensors, St. Jude Medical, and Biotronik; and
honoraria for serving on the advisory board and Speakers Bureau of Abbott
Vascular, Boston Scientiﬁc, Biosensors, St. Jude Medical, Biotronik, Volcano,
Lilly, and AstraZeneca. Drs. Hernandez and Alfonso have reported that they do
not have any relationships relevant to the contents of this paper to disclose.
RE F E RENCE S
1. Park SJ, Ahn JM, Kang SJ, et al. Intravascular ultrasound-derived minimal
lumen area criteria for functionally signiﬁcant left main coronary artery
stenosis. J Am Coll Cardiol Intv 2014;7:868–74.
2. Jasti V, Ivan E, Yalamanchili V, Wongpraparut N, Leesar MA. Correlations
between fractional ﬂow reserve and intravascular ultrasound in patients with
an ambiguous left main coronary artery stenosis. Circulation 2004;110:
2831–6.
3. Rusinova RP, Mintz GS, Choi SY, et al. Intravascular ultrasound comparison
of left main coronary artery disease between white and Asian patients. Am J
Cardiol 2013;111:979–84.
4. de la Torre Hernandez JM, Hernandez Hernandez F, Alfonso F, et al.
Prospective application of pre-deﬁned intravascular ultrasound criteria
for assessment of intermediate left main coronary artery lesions
results from the multicenter LITRO study. J Am Coll Cardiol 2011;58:
351–8.
5. Finet G, Gilard M, Perrenot B, et al. Fractal geometry of arterial coronary
bifurcations: a quantitative coronary angiography and intravascular ultrasound
analysis. EuroIntervention 2008;3:490–8.
6. Waksman R, Legutko J, Singh J, et al. FIRST: Fractional Flow Reserve and
Intravascular Ultrasound Relationship Study. J Am Coll Cardiol 2013;61:
917–23.
J A C C : C A R D I O V A S C U L A R I N T E R V E N T I O N S V O L . 8 , N O . 1 , 2 0 1 5 Letters to the Editor
J A N U A R Y 2 0 1 5 : 1 1 9 – 2 7
123REPLY: The Optimal Cutoff Value for Left
Main Minimal Lumen Area of 4.5 mm2:
A Word of Caution
We thank Dr. de la Torre Hernández and colleagues
for their interest in our paper (1) suggesting the
optimal left main coronary artery minimal lumen area
(LM-MLA) of 4.5 mm2 for detecting fractional ﬂow
reserve (FFR) <0.80.
First, the Jasti et al. (2) study with a small sample
size (N ¼ 55) reporting an LM-MLA cutoff value of
5.9 mm2 enrolled patients with lesions with down-
stream disease of the LM branches; 58% were distal
LM lesions usually extending to the side-branch ostia,
which made assessing how the LM-MLA itself affects
the hemodynamic signiﬁcance unreliable. Moreover,
they included only a few patients with an MLA of 4.5
to 6.0 mm2. The lesions mostly had a large lumen,
with 75% having a negative FFR. Conversely, our
study (N ¼ 112) included only ostial and shaft lesions:
34 patients with an LM-MLA of 4.5 to 6.0 mm2 and
more ischemia-inducing lesions and 59% with posi-
tive FFR (<0.80). That is the main difference in our
study. The ethnic differences poorly supported the
relevance of using the larger LM-MLA criterion.
Rusinova et al. (3) reported a smaller LM-MLA in
Asian patients, whereas the vessel area was greater
in Asian compared with North American patients
(20.7  4.5 mm2 vs. 19.3  4.2 mm2, p ¼ 0.024).
Second, the suboptimal accuracy of the LM-MLA is
not surprising. Even in isolated LM lesions, the FFR
was determined not only by the LM-MLA but also by
various clinical and lesion-speciﬁc local factors (age,
body mass index, left ventricular mass, and the
presence of plaque rupture) (1). In patients with an
LM-MLA >4.5 mm2, the FFR was <0.80 in 24%,
but <0.75 in only 9%. However, 36% of the patients
with an LM-MLA <6.0 mm2 showed an FFR>0.80, and
they are at risk of undergoing unnecessary treatment.
Third, if an MLA of 3.0 mm2 for the left anterior
descending artery and 2.7 mm2 for the left circumﬂex
artery are assumed to be ischemic thresholds, clearly
the LM-MLA is 4.5 mm2 (Murray’s law) (1).
Fourth, in the LITRO trial (4), 16 of the 168 patients
with an LM MLA <6 mm2 did not undergo revascu-
larization. They had an LM-MLA of 5.0 to 6.0 mm2 and
had complex lesion morphology for PCI, high surgical
risk, old age, and multiple comorbidities. The worse
cardiac plug) in a relatively large cohort of 120 pa-
tients, there were several issues in methodology that
need to be clariﬁed and discussed.
Ideal ICE imaging views and accurate measure-
ment of the LAA anatomy including the ostium, short-
and long-axes, and the landing zone are critically
important for proper sizing and delivery. Although
they failed to present a uniform ICE examination
protocol, they describe imaging the LAA with the
transducer in the right atrium (RA) and coronary sinus
(CS). In majority of the atrial ﬁbrillation patients with
LA enlargement, the RA transducer view does not
provide anatomically detailed LAA imaging with suf-
ﬁcient resolution due to far-zone imaging features.
The authors try to argue against this with a “best
example” ﬁgure (Figure 2 [1]), but it appears that the
transducer in this ﬁgure is actually in the LA because
the interatrial septum is not imaged. In addition,
when imaging from the CS, the LAA is often truncated,
and it is difﬁcult to obtain an ideal LAA ostium and
LAA long-axis image due to the limited potential for
transducer manipulation in the narrow CS lumen.
In our experience using ICE for cardiac diagnosis
and left heart ablation in more than 3,000 cases,
speciﬁc imaging views routinely provide important
LAA anatomic features as part of a complete assess-
ment (2). A transverse long-axis image of LAA with its
oriﬁce can be typically obtained with the transducer
placed in the right ventricular outﬂow tract (RVOT).
This imaging view is especially helpful for anatomic
assessment and LAA size measurements (Figure 1A).
Close-up imaging using higher ultrasonic frequency
can be obtained with the transducer placed in the
pulmonary artery (PA). These imaging views are
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124outcome in those ineligible for the protocol could not
represent the general population.
Finally, no evidence-based criteria warrant revas-
cularization for vulnerable lesions without ischemia.
The FFR is the most sensitive index of ischemia in
all clinical settings except ST-segment elevation
myocardial infarction. Thus, LM-MLA may be useful
to aid in decision making as to whether to treat, but
choose the cutoff value wisely! If you still doubt
about objective ischemia, please use the FFR!
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Echocardiographic
Imaging of the Left Atrial
Appendage and Detection
of a Peridevice Leak After
Device Occlusion
We read with great interest the report by Berti et al.
(1). We agree with their view point that intracardiac
echocardiography (ICE) imaging can perform the
tasks typically provided by transesophageal echocar-
diography (TEE) during transcatheter occlusion of the
left atrial (LA) appendage (LAA). Although the au-
thors presented utility and safety assessment of ICE-
guided percutaneous LAA device closure (Amplatzer
especially helpful for differentiation of thrombus
from variant pectinate muscles/sluggish ﬂow and
to properly image/measure LAA emptying ﬂow
(Figure 1B). Peripheral LAA–left ventricle imaging
views can also be obtained with the transducer placed
in PA for close-up evaluation of lobes and pectinate
muscles (2). Therefore, the best view for measurement
of the anatomy of the LAA is the ICE transducer placed
in the RVOT. The LAA ostium is usually measured
from the LAA junction with the upper left pulmonary
vein (ULPV) ostium to the junction of the LA and
LAA (Figure 1A). The landing-zone diameter can be
accurately determined with a certain distance to the
ostium. In addition, this view also provides the best
imaging to guide proper sheath/device placement in
the LA to LAA ostium, much better than the ideal
lobe for sheath placement that was decided on based
on ﬂuoroscopic images indicated by the authors (1).
Another important issue is to evaluate/eliminate
any peridevice leak immediately after device
